Catalent specializes in the research, development, and production of injectable pharmaceuticals, with a particular emphasis on extended-release drug systems. Our expertise includes the development and manufacture of complex formulations such as microspheres, liposomes, lipid nanoparticles, and micellar solutions.
Catalent’s state-of-the-art research and development laboratories are equipped with cutting-edge technologies, supported by a highly skilled team that drives the creation of a broad range of products. Through our Contract Development and Manufacturing Organization (CDMO) services, we offer our advanced development and manufacturing capabilities to partner companies.
We are eager to explore collaboration opportunities with other organizations seeking to leverage Catalent’s extensive expertise in product development and manufacturing.
Catalent's national and international objectives and strategic goals. This manufacturing plant operates with a dual focus, aiming to serve both national healthcare needs and contribute to international pharmaceutical supply chains. Our approach involves producing a comprehensive range of medicines, encompassing both proprietary formulations and trusted licensed products from other companies. This enables us to address a wide spectrum of therapeutic areas, including but not limited to Urology, Oncology, Women’s Health, and general hospital medications, while adhering to the highest global standards of quality and reliability across our entire portfolio. Our dedicated teams are committed to delivering innovative and generic solutions to national health sectors worldwide and to international markets, ensuring a consistent and dependable supply of essential medicines
